Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.020 CAD
−2.62 M CAD
100.44 K CAD
106.83 M
About Appili Therapeutics Inc Class A
Sector
Industry
CEO
Don Cilla
Website
Headquarters
Halifax
Founded
2015
ISIN
CA03783R1073
FIGI
BBG00PH28LQ8
Appili Therapeutics, Inc. operates as a biopharmaceutical company, which acquires and develops novel treatments targeting unmet needs in infectious disease. It focuses on building and advancing a diverse portfolio of anti-infective programs such as ATI-1501, ATI-1503, and ATI-1701. The company was founded on May 7, 2015 and is headquartered in Halifax, Canada.
Related stocks
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of APLI is 0.015 CAD — it hasn't changed in the past 24 hours. Watch Appili Therapeutics Inc Class A stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSX exchange Appili Therapeutics Inc Class A stocks are traded under the ticker APLI.
APLI stock hasn't changed in a week, the month change is a −25.00% fall, over the last year Appili Therapeutics Inc Class A has showed a −50.00% decrease.
APLI reached its all-time high on May 20, 2020 with the price of 1.890 CAD, and its all-time low was 0.010 CAD and was reached on Jun 17, 2025. View more price dynamics on APLI chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
APLI stock is 0.00% volatile and has beta coefficient of 1.47. Track Appili Therapeutics Inc Class A stock price on the chart and check out the list of the most volatile stocks — is Appili Therapeutics Inc Class A there?
Yes, you can track Appili Therapeutics Inc Class A financials in yearly and quarterly reports right on TradingView.
Appili Therapeutics Inc Class A is going to release the next earnings report on Nov 13, 2025. Keep track of upcoming events with our Earnings Calendar.
APLI net income for the last quarter is −1.25 M CAD, while the quarter before that showed 236.15 K CAD of net income which accounts for −629.15% change. Track more Appili Therapeutics Inc Class A financial stats to get the full picture.
No, APLI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 21, 2025, the company has 7 employees. See our rating of the largest employees — is Appili Therapeutics Inc Class A on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Appili Therapeutics Inc Class A EBITDA is −8.88 M CAD, and current EBITDA margin is −9.69 K%. See more stats in Appili Therapeutics Inc Class A financial statements.
Like other stocks, APLI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Appili Therapeutics Inc Class A stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Appili Therapeutics Inc Class A technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Appili Therapeutics Inc Class A stock shows the sell signal. See more of Appili Therapeutics Inc Class A technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.